Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... Table 2.4a) Patients must have a related or unrelated peripheral blood stem cell donor as follows: Sibling donor must be a 6/6 match for ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  2. Total Marrow Irradiation for Refractory Acute Leukemia

    ... and total marrow irradiation before a donor umbilical cord blood or hematopoietic stem cell transplant helps stop the growth of cancer cells. It may also ... Transplant Program guidelines. Other Name: mobilized peripheral blood stem cells ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  3. Transplantation Basics

    ... are gathered from either bone marrow , umbilical cord blood, and peripheral blood of a suitable donor and are placed in an MDS patient? ...

    Interview last updated 04/05/2013 - 2:33pm.

  4. Busulfan and Cyclophosphamide Followed By ALLO BMT

    ... Oncore (clinical database) and the University of Minnesota Blood and Marrow Database as part of the historical database maintained by the ... antigen match) HLA-matched related or unrelated donor peripheral blood stem cells related or single or double unrelated donor ...

    Clinical Trial last updated 04/29/2016 - 1:23pm.

  5. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... DR loci) by high resolution DNA typing Must have donor peripheral blood stem cells mobilized by NMDP standards. No bone marrow ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.

  6. Nonmyeloablative Haploidentical Transplant Followed by MLN9708

    ... to improve NK cell reconstitution following haploidentical peripheral blood stem cell transplantation. Patients will receive a nonmyeloablative ...

    Clinical Trial last updated 04/29/2016 - 1:05pm.

  7. Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

    ... This research study uses special blood cells called multiple tumor-associated antigen (TAA)-specific T cells (a ... by intravenous injection over 1-10 minutes through either a peripheral or central lie. If patients with residual disease (Group B) have ...

    Clinical Trial last updated 04/28/2016 - 11:40am.

  8. A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

    ... on day -6 and cluster of differentiation (CD)-34+ allogeneic peripheral blood stem cell transplantation (PBSCT) on day 0. GVHD PROPHYLAXIS: ...

    Clinical Trial last updated 04/27/2016 - 1:56pm.

  9. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... Purpose:  RATIONALE: A peripheral stem cell transplant may be able to replace blood-forming cells that were destroyed by chemotherapy and radiation ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  10. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... after transplant. Eligibility: - Adults 18 70 with blood or bone marrow cancer with no HLA-matched sibling, but with a ... or blast phase must have < 5% blasts in the peripheral blood and bone marrow. Persons with chronic phase CML may have up to ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.